Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 15, 2025 02:30 ET | Source: Curium

Curium Group, PeptiDream and PDRadiopharma Enroll First Patient to Registrational Clinical Trial of 64Cu-PSMA-I&T for Prostate Cancer in Japan

PARIS, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Curium Group announced today that together with PeptiDream Inc. and PDRadiopharma Inc., a registrational Phase 2 clinical trial has been initiated in Japan...
October 08, 2025 06:22 ET | Source: Curium

Oxford Set To Benefit From New Technology to Diagnose Disease

Curium will shortly open a new facility to manufacture cutting-edge diagnosis technology for diseases like cancer at the Churchill Hospital site, part of Oxford University Hospitals NHS Foundation...
October 08, 2025 06:22 ET | Source: Curium

Newcastle Set To Benefit From New Technology to Diagnose Disease

Newcastle University has entered into a lease agreement with Curium for a new site dedicated to the manufacture of cutting-edge diagnostic technologies for diseases such as cancer. The facility will...
May 21, 2025 05:42 ET | Source: Curium

Curium and NRG PALLAS extend collaboration in the supply of essential medical isotope to hospitals

PETTEN, The Netherlands, May 21, 2025 (GLOBE NEWSWIRE) -- NRG PALLAS and Curium have extended their collaboration to produce molybdenum-99 through a new multi-year agreement. Molybdenum-99, which...
May 12, 2025 07:05 ET | Source: Curium

Curium receives marketing authorization in Switzerland for PYLCLARI® – an innovative 18F-PSMA PET tracer indicated in patients with prostate cancer

Swissmedic grants marketing authorization for PYLCLARI® in Switzerland b.e. Imaging is marketing authorization holder and has exclusive distribution rights for PYLCLARI® across Switzerland ZURICH,...
April 10, 2025 05:00 ET | Source: Curium

Curium strengthens its PET manufacturing capacity and expands European footprint with the acquisition of Nucleis

The acquisition of Nucleis will: Enhance Curium’s PET manufacturing capacity and radiopharmaceutical distribution network of 32 PET sites in Western EuropeImprove reliability and accessibility...
April 02, 2025 00:01 ET | Source: Curium

Curium Announces Approval of Generic DTPA - Kit for the Preparation of Technetium Tc 99m Pentetate Injection in the U.S.

ST. LOUIS, April 02, 2025 (GLOBE NEWSWIRE) -- Curium announced today that the U.S. Food and Drug Administration approved its generic version of the Kit for the Preparation of Technetium Tc 99m...
March 28, 2025 19:40 ET | Source: Curium US LLC

キュリウム (Curium)、ルテチウム177の供給能力およびPET分野の事業拡大計画の一環としてモンロール (Monrol) の買収を完了

キュリウムは、ルテチウム177アイソトープの主要製造企業としての地位を確立革新的な研究開発の専門性および開発パイプラインをキュリウムにもたらすSPECTおよびPETにおけるキュリウムの地理的展開とサプライチェーンを強化パリ発, March 29, 2025 (GLOBE NEWSWIRE) -- 核医学の世界的リーダーであるキュリウム・ファーマ (Curium Pharma)...
March 28, 2025 19:40 ET | Source: Curium US LLC

Curium משלימה את רכישת Monrol כחלק מהתוכנית שלה להרחיב משמעותית את הקיבולת של לוטיציום-177 וטביעת הרגל של השימוש ב-PET

*תמצב את Curium כיצרנית מובילה של איזוטופ לוטיציום-177 *מביאה מומחיות מו"פ חדשנית וצנרת ייצור ל-Curium *משפרת את הכיסוי הגיאוגרפי ואת שרשרת האספקה של עבור ה-SPECT & PET של Curium פריז, March ...
March 28, 2025 19:40 ET | Source: Curium US LLC

Curium finalise l’acquisition de Monrol, axée sur le net renforcement de sa capacité de production de lutécium-177 et de son empreinte PET

Affirmation de son leadership dans la production de l’isotope lutétium-177Renforcement de son expertise en R&D et consolidation de son pipeline innovantExtension de sa couverture géographique et...